ask="N/A"
ask_size="N/A"
average_daily_volume="1276530"
bid="N/A"
bid_size="N/A"
book_value="0.07"
change="-0.00"
change_from_200_day_moving_average="-0.05"
change_from_50_day_moving_average="0.00"
change_from_52_week_high="-0.26"
change_From_52_week_low="0.03"
change_in_percent="-1.17%"
close="0.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.06"
ebitda="-16.83M"
eps_estimate_current_year="-0.07"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.10"
ex_dividend_date="N/A"
float_shares="215606000"
high="0.17"
high_52_weeks="0.42"
last_trade_date="1/12/2017"
last_trade_price="0.16"
last_trade_size="400"
last_trade_time="4:02pm"
low="0.16"
low_52_weeks="0.13"
market_capitalization="37.98M"
moving_average_200_day="0.21"
moving_average_50_day="0.16"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.50"
open="0.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-23.68%"
percent_change_from_50_day_moving_average="+1.54%"
percent_change_from_52_week_high="-61.90%"
percent_change_from_52_week_low="+23.08%"
previous_close="0.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237368000"
short_ratio="2.48"
stock_exchange="ASE"
symbol="RNN"
volume="1162748"
weeks_range_52="0.13 - 0.42"
